Cell Transformation, Neoplastic: Clinical Trials

5 trials for Cell Transformation, Neoplastic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5

Follow Cell Transformation, Neoplastic: new trials by email Literature Review of Cell Transformation, Neoplastic trials Research Report on Cell Transformation, Neoplastic

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
danusertib, laboratory biomarker analysis, pharmacological study - Leukemia
Phase 2UnknownJonsson Comprehensive Cancer Center162007-03-012013-12-18
Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation
management of therapy complications, pain therapy - Chronic Myeloproliferative Disorders, Kidney Cancer
Phase 2UnknownMedical College of Wisconsin802002-01-012013-09-20
Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders
anti-thymocyte globulin, cyclosporine, fludarabine phosphate - Leukemia, Lymphoma
Phase 2UnknownHerbert Irving Comprehensive Cancer Center521998-04-012014-01-06
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
arsenic trioxide - Leukemia, Lymphoma
Phase 2UnknownOur Lady of Mercy Medical Center601997-11-012013-11-06
Umbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic Anemia
umbilical cord blood transplantation - Childhood Langerhans Cell Histiocytosis, Leukemia
Phase 2UnknownHerbert Irving Comprehensive Cancer Center301997-01-012013-12-18

Narrower conditions

Blast Crisis (5)  ·  Leukemia (5)  ·  Burkitt Lymphoma (4)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (4)  ·  Leukemia, Myeloid, Accelerated Phase (4)  ·  Leukemia, Myeloid, Chronic-Phase (4)  ·  Lymphoma (4)  ·  Multiple Myeloma (4)  ·  Myelodysplastic Syndromes (4)  ·  Neoplasms, Plasma Cell (4)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Dendritic Cell Sarcoma, Interdigitating (3)  ·  Leukemia, Myeloid, Acute (3)  ·  Lymphoma, B-Cell, Marginal Zone (3)  ·  Lymphoma, Follicular (3)

Broader conditions

Bone Marrow Diseases (5)  ·  Carcinogenesis (5)  ·  Chronic Disease (5)  ·  Disease Attributes (5)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Leukemia, Myeloid (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Neoplastic Processes (5)  ·  Pathologic Processes (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Blood Protein Disorders (4)  ·  Cardiovascular Diseases (4)

Interventions

Analgesia (1)  ·  Antilymphocyte Serum (1)  ·  Arsenic Trioxide (1)  ·  Cord Blood Stem Cell Transplantation (1)  ·  Cyclosporine (1)  ·  Melphalan (1)  ·  Methylprednisolone (1)  ·  Mycophenolic Acid (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  danusertib (1)  ·  fludarabine phosphate (1)

Sponsors

Herbert Irving Comprehensive Cancer Center (2)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Medical College of Wisconsin (1)  ·  Our Lady of Mercy Medical Center (1)

Countries

United States (5)

Top investigators

David G. Savage, MD (2)  ·  Harry T. Whelan, MD (1)  ·  Janice P. Dutcher, MD (1)  ·  Ronald Paquette, MD (1)

Results publications

PMID 15107815